Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-05-19 @ 11:00 AM
Study NCT ID:
NCT02133157
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2014-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors
Sponsor:
Hutchison Medipharma Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2009-012-00CH1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None